U.S. Physical Therapy, Inc. (USPH) Guidance & Earnings Results
On 2026-05-06 U.S. Physical Therapy, Inc. reaffirmed guidance: "FY2026 adjusted EBITDA…" — from its own filing, as read by EquiReason.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
USPHU.S. Physical Therapy, Inc.Follow USPH — free
—
Price chart with a free account
- Market cap
- 1.3B
- P/E TTM
- —
- Dividend yield
- 2.1%
- 52-week
- —
- Next earnings
- 4 Nov, in 11 days
What management guided
each earnings 8-K · figures checked against the filing text| Release | Direction | What they said |
|---|---|---|
| 6 May 26 | Reaffirmed | FY2026 adjusted EBITDA $102.0M-$106.0M · full year |
| 6 Nov 25 | Reaffirmed | Adjusted EBITDA $93M to $97M for full year 2025 · full year |
| 7 Aug 25 | Raised | FY25 Adjusted EBITDA raised to $93.0-97.0M from prior range (not stated in excerpt); Q2 dividend $0.45/share; $25M buyback authorized through Dec 2026 · full year |
U.S. Physical Therapy, Inc. — questions
- What guidance did U.S. Physical Therapy, Inc. give?
- On 2026-05-06: "FY2026 adjusted EBITDA $102.0M-$106.0M"
- When does U.S. Physical Therapy, Inc. report earnings?
- U.S. Physical Therapy, Inc.'s next earnings report is expected on 2026-11-04.
Every figure on this page comes from U.S. Physical Therapy, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.